Significant Ownership of Coastlands Capital LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Coastlands Capital LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Mark Shamia - Chief Operating Officer of the General Partner, Coastlands Capital LLC
Manager location
San Francisco, CA

Follow Filing Activity

Follow Coastlands Capital LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of Coastlands Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADIL Adial Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 14% $1,112,500 +$331,242 373,322 +42% Coastlands Capital LP 24 Jun 2026
KTTA Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share 11% $2,339,371 +$878,565 3,835,035 +60% Coastlands Capital LP 09 Apr 2026
CAMP Camp4 Therapeutics Corp Common stock, par value $0.0001 per share 10% $21,452,710 4,886,722 Coastlands Capital LP 10 Sep 2025
NERV Minerva Neurosciences, Inc. Common Stock, par value $0.0001 per share 10% $18,571,536 4,563,031 Coastlands Capital LP 13 Feb 2026
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 10% $7,773,911 +$37,418 2,491,638 +0.48% Coastlands Capital LP 03 Oct 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $3,742,248 5,346,069 Coastlands Capital LP 04 Dec 2025
ELOX Eloxx Pharmaceuticals, Inc. Common Stock, par value $0.01 per share 10% 410,530 +54% Coastlands Capital LP 10 Jun 2026
WHWK Whitehawk Therapeutics, Inc. Common stock 6% $5,074,587 2,819,215 Coastlands Capital LP 19 Aug 2025
ELDN Eledon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5% $6,733,682 -$1,410,519 3,937,826 -17% Coastlands Capital LP 31 Dec 2025
NEUP Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share 4.2% $992,007 +$471,255 228,594 +90% Coastlands Capital LP 23 Jul 2026

Schedules 13D/G Reported by Coastlands Capital LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .